In depth 

Seven steps to healthy profits

Seven steps to healthy profits

There’s a lot of money to be made in British healthcare, just ask Jonathon Milner. The Cambridge scientist retained a 28 per cent stake in his £58m antibody catalogue business when he listed it on London’s junior market in 2005. Thirteen years and an eight-fold share price increase later and Abcam (ABC) is one of Aim’s biggest companies. Mr Milner – who has made regular share sales in the last few years – now owns 10 per cent of the group, a stake that is worth £250m. 

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now